Alikhani N, Ferguson RD and Novosyadlyy R 2013 Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. Oncogene 32 961–967

Article  CAS  PubMed  Google Scholar 

Athavale D, Chouhan S, Pandey V, et al. 2018 Hepatocellular carcinoma-associated hypercholesterolemia: Involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9). Cancer Metab. 6 16

Article  PubMed  PubMed Central  Google Scholar 

Bandyopadhyay S, Li J, Traer E, et al. 2017 Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia. PLoS One 12 e0179558

Article  PubMed  PubMed Central  Google Scholar 

Beloribi-Djefaflia S, Vasseur S and Guillaumond F 2016 Lipid metabolic reprogramming in cancer cells. Oncogenesis 5 e189

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bil J, Zapala L, Nowis D, et al. 2010 Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro. Cancer Lett. 288 57–67

Article  CAS  PubMed  Google Scholar 

Cabodevilla AG, Sanchez-Caballero L, Nintou E, et al. 2013 Cell survival during complete nutrient deprivation depends on lipid droplet-fueled B-oxidation of fatty acids. J. Biol. Chem. 288 27777–27788

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chae YK, Yousaf M, Malecek MK, et al. 2015 Statins as anti-cancer therapy; Can we translate preclinical and epidemiologic data into clinical benefit? Discov. Med. 20 413–427

PubMed  Google Scholar 

Chan KKW, Oza AM and Siu LL 2003 The statins as anticancer agents. Clin. Cancer Res. 9 10–19

CAS  PubMed  Google Scholar 

Chang T, Li B, Chang CCY, et al. 2009 Acyl-coenzyme A: Cholesterol acyltransferases. Am. J. Physiol. Endocrinol. Metab. 297 1–17

Article  Google Scholar 

Chen Y, Liu YC, Sung YC, et al. 2017 Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors. Sci. Rep. 7 1–12

Google Scholar 

Cheng Y, Luo R, Zheng H, et al. 2017 Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma. Oncotarget 8 23265–23276

Article  PubMed  PubMed Central  Google Scholar 

Cheng C, Geng F, Cheng X, et al. 2018 Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun. 38 27

Article  Google Scholar 

Clendening JW and Penn LZ 2012 Targeting tumor cell metabolism with statins. Oncogene 31 4967–4978

Article  CAS  PubMed  Google Scholar 

Crissien AM and Frenette C 2014 Current management of hepatocellular carcinoma. Gastroenterol. Hepatol. 10 153–161

Google Scholar 

Geng F, Cheng X, Wu X, et al. 2016 Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis. Clin. Cancer Res. 22 5337–5348

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greenspan P, Mayer EP and Fowler SD 1985 Nile Red: A selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100 965–973

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta S, Kass GEN, Szegezdi E, et al. 2009 The mitochondrial death pathway: A promising therapeutic target in diseases. J. Cell. Mol. Med. 13 1004–1033

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han J and Kaufman RJ 2016 The role of ER stress in lipid metabolism and lipotoxicity. J. Lipid Res. 57 1329–1338

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hwang SJ, Lee SD, Chang CF, et al. 1992 Hypercholesterolaemia in patients with hepatocellular carcinoma. J. Gastroenterol. Hepatol. 7 491–496

Article  CAS  PubMed  Google Scholar 

Insull W, Koren M, Davignon J, et al. 2001 Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. Atherosclerosis 157 137–144

Article  CAS  PubMed  Google Scholar 

Jiang P, Mukthavaram R, Chao Y, et al. 2014 In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. Br. J. Cancer 111 1562–1571

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karch J and Molkentin JD 2015 Regulated necrotic cell death: The passive aggressive side of bax and bak. Circ. Res. 116 1800–1809

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kudo M 2018 Systemic therapy for hepatocellular carcinoma: Recent advances. Acta Hepatol. Jpn. 59 587–603

Article  CAS  Google Scholar 

Kuzu OF, Noory MA and Robertson GP 2016 The role of cholesterol in cancer. Cancer Res. 76 2063–2070

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Gu, Lee SSY et al. 2016 Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer. Oncogene 35 6378–6388

Li J, Qu X, Tian J, et al. 2018 Cholesterol esterification inhibition and gemcitabine synergistically suppresses pancreatic ductal adenocarcinoma proliferation. PLoS One 13 1–11

Google Scholar 

Liu JY, Fu WQ, Zheng XJ, et al. 2021 Avasimibe exerts anticancer effects on human glioblastoma cells via inducing cell apoptosis and cell cycle arrest. Acta Pharmacol. Sin. 42 97–107

Article  PubMed  Google Scholar 

Llovet JM, Zucman-Rossi J, Pikarsky E, et al. 2016 Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 2 16018

Article  PubMed  Google Scholar 

Manov I, Pollak Y, Broneshter R, et al. 2011 Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib: The role of extracellular signal-regulated kinase counteraction. FEBS J. 278 3494–3507

Article  CAS  PubMed  Google Scholar 

Mayengbam SS, Singh A, Yaduvanshi H, et al. 2023 Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells. Cancer Metab. 11 15

Article  PubMed  PubMed Central  Google Scholar 

Mohammad N, Malvi P, Meena A, et al. 2014 Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma. Mol. Cancer 13 204

Article  PubMed  PubMed Central  Google Scholar 

Montero J, Morales A, Llacuna L, et al. 2008 Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. Cancer Res. 68 5246–5256

Article  CAS  PubMed  Google Scholar 

Nagai T, Arao T, Furuta K, et al. 2011 Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma. Mol. Cancer Ther. 10 169–177

Article  CAS  PubMed  Google Scholar 

Naito S, Makhov P, Astsaturov I, et al. 2017 LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma. Br. J. Cancer 116 1203–1207

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oldoni F, Sinke RJ and Kuivenhoven JA 2014 Mendelian disorders of high-density lipo